General
Chemicals. Chemicals and dry solvents were purchased from commercial suppliers and used without further purification. Adenosine 5'-monophosphate (AMP, free acid) was purchased from Carbosynth Ltd. (Berkshire, UK), cytidine 5'-monophosphate (CMP, disodium salt) from Sigma Aldrich (Deisenhofen, Germany), uridine 5'-monophosphate (UMP, disodium salt) from Acros (Geel, Belgium), and guanosine 5'-monophosphate (GMP, disodium salt monohydrate) from TCI (Zwijndrecht, Belgium). Preactivated nucleotide 2-MeIm-AMP S1 was synthesized according to the published procedures. D 2 O (99.90% deuterated) was purchased from Euriso-Top (Saint-Aubin, France). NMR Spectroscopy. NMR spectra were acquired on a Bruker Avance III HD spectrometer (proton resonance frequency 700.36 MHz, phosphorous frequency 283.5 MHz) or a Bruker Avance III HD-NanoBay spectrometer (proton resonance frequency 400.10 MHz, phosphorous frequency 162 MHz). 1 H-NMR spectra were measured in the presence of either 3-(trimethylsilyl)-1-propanesulfonic acid sodium salt or 3-(trimethylsilyl)-propionic-2,2,3,3,-d 4 acid sodium salt as an internal standard.
MALDI-TOF MS. MALDI-TOF mass spectra were acquired on a Bruker Microflex mass spectrometer (Bruker Daltonics, Bremen, Germany) in linear negative mode. A mixture of 2:1 (v:v) of a 2,4,6-trihydroxyacetophenone solution (0.2 M in ethanol) and a diammonium citrate solution (0.1 M in H 2 O) were used as matrix and co-matrix, respectively. ESI-HRMS. High resolution mass spectra were recorded on a micrOTOF-Q mass spectrometer (Bruker Daltonics, Bremen, Germany), either in negative or positive mode. Chromatography.
Purification of oligonucleotides via cartridge used Sep-Pak Vac C18 3cc RP-cartridges or Sep-Pak Vac QMA 3cc IEX-cartridges (Waters, Milford, MA, USA). The C18 cartridges were rinsed with MeCN and aqueous triethylammonium acetate (TEAA) buffer solution (100 mM, pH 7.5) before applying the product solution; QMA-cartridges were washed with a solution of (NH 4 ) 2 CO 3 in H 2 O (5 mM, pH 8.0).
Alternatively, anion-exchange chromatography was performed on Express-Ion DEAE cellulose from GE Healthcare (Buckinghamshire, UK). Details are given in the respective sections, below. HPLC. 
Reversed

Synthesis of Reference Compounds
Scheme S1. Synthesis routes to reference compounds. Chain extension was by automatic RNA synthesis, subsequent coupling to dipeptido dinucleotides or pyrophosphate-capped dinucleotides was by solution phase syntheses. The route shown is for the 3',5'-regioisomer and adenine as nucleobase and is representative. See the General Protocols, below, for details.
Synthesis of Dinucleotides (General Protocol A).
The following protocol describes the synthesis of pGG and is representative for all dinucleotides. Solid-phase synthesis started from cpg loaded with the guanosine nucleoside (80 mg, 2 mol). The first coupling cycle was performed with the 3'-TBDMS protected guanosine building block and the second with 'chemical phosphorylation reagent'. Afterwards, the solid support was treated with aqueous ammonia/aqueous methylamine (1:1 v/v; "AMA") solution (750 L) for 15 min at 55 °C. The supernatant was harvested, and the residue was washed three times with H 2 O (3 × 500 L).
The combined aqueous solutions were freed from ammonia and methylamine with a nitrogen stream directed onto the surface of the solution and then lyophilized to dryness. The resulting solid was dissolved in TEAA buffer (1 mL, 100 mM) and loaded onto a C18 SepPac cartridge (500 mg). The TBDMS-protected dinucleotide was eluted with a gradient of MeCN in TEAA buffer (0-25% MeCN, in 5% steps, 5 mL each). Product-containing fractions were collected and lyophilized. The resulting solid was dissolved in triethylamine trihydrofluoride (750 L) and the solution was allowed to shake for 5 h at room temperature. Then, methoxytrimethylsilane (5 mL) was added, and the mixture was shaken vigorously for 5 min.
The suspension was centrifuged for 5 min, and the supernatant was decanted off. The pellet was dissolved in TEAA buffer (1 mL, 100 mM) and again loaded onto a C18 SepPac cartridge (500 mg). After rinsing with TEAA buffer (4.5 mL, 100 mM) the deprotected dinucleotide was eluted with H 2 O (10 mL). Fractions containing the fully deprotected dinucleotide were pooled and dried in vacuo.
Synthesis of 5'-Pyrophosphate-Capped Dinucleotides (General Protocol B).
The following protocol is for AppAA and is representative. A sample of pAA (triethylammonium salt, 0.88 mg, 1.0 mol, 1.0 equiv) was dissolved in a buffer solution (15 L) containing HEPES (1.8 mg, 7.5 mol, 500 mM) and MgCl 2 (0.11 mg, 1.2 mol, 80 mM) at pH 7.5.
Then, 2-MeIm-AMP (2.64 mg, 6.1 mol, 6.1 equiv, 510 mM) was added, and the reaction mixture was incubated at 40 °C. After 16 h, additional 2-MeIm-AMP (1.02 mg, 2.4 mol, 2.4 equiv) was added, and the reaction was allowed to proceed for 5 h at 40 °C. Then, the product was pre-purified by anion exchange chromatography (DEAE cellulose), using a stepgradient of ammonium bicarbonate in H 2 O (0-200 mM bicarbonate, 20 mM steps, 6 mL each). Products were detected in fractions with 140-200 mM bicarbonate. The fractions were collected, freeze-dried, and the product was re-purified by HPLC (C18, MeCN gradient in 100 mM aqueous TEAA buffer, 0% to 15% in 45 min, t R = 31 min). Excess TEAA buffer was removed via C18 SepPac cartridge. The product was dissolved in TEAA buffer (1 mL, 100 mM) and loaded on the cartridge (500 mg). After washing with water (6 mL), the product was eluted with a solution of MeCN in H 2 O (6 mL, 5% MeCN). The solvents were removed by lyophilization to obtain a colorless powder.
Synthesis of Dipeptido Dinucleotides (General Protocol C). This protocol is for
GlyGlyAA and is representative. The triethylammonium salt of dinucleotide pAA (0.22 mg, 250 nmol, 1.0 equiv) was dissolved in a freshly prepared solution (D 2 O, 100 L) containing EDC hydrochloride (15.3 mg, 80 mol, 320 equiv, 800 mM) and DMAP (1.80 mg, 15 mol, 60 equiv, 150 mM) at pH 8.0, uncorrected for deuterium effect. After 3 h at 22 °C, the reaction mixture was added to a solution of NaClO 4 in acetone/Et 2 O (3 mL, 0.1 M, 1:1 v/v) at 0 °C. After vigorous shaking, the suspension was kept in an ice bath for 10 min. Then, the suspension was centrifuged for 5 min, and the supernatant was decanted. The pellet thus obtained was washed with Et 2 O (1 mL) twice, and then dried at 15 mbar in a desiccator. The pellet was dissolved in a solution of glycylglycine (7.92 mg, 60 mol, 240 equiv, 300 mM) in D 2 O (200 L) at pH = 7.5. The reaction mixture was incubated for 3 h at 22 °C. Afterwards, the solution was diluted with TEAA buffer (1 mL, 100 mM) and loaded onto a C18 SepPac cartridge (500 mg). The product was eluted with a step gradient of MeCN in 100 mM TEAA buffer (0-14%, 2%-steps, 2 mL each). Product-containing fractions (6-8% MeCN) were pooled and lyophilized. Residual TEAA buffer was removed by adsorbing the product on a C18 SepPac cartridge, followed by elution with water/acetonitrile and lyophilization, as described in General Protocol B.
Analytical Data for Dinucleotides
The NMR data of 3',5'-dimers pAA, pCC, pUU, and pGG were in agreement with those reported recently. [S3] Dimer pAA. Fractions containing product (100 and 120 mM bicarbonate) were collected and lyophilized.
The dipeptido dinucleotide (ammonium salt) was recovered as a white solid (0.20 mg, 235 nmol, 94%). 
Oligomerization Assays
Representative Protocols for Oligomerization Assays
Oligomerization of Ribonucleotides. The following protocol is for the oligomerization of AMP and is representative for the NMP oligomerization assays. To AMP (free acid, 34.7 mg, 100 mol), glycine (7.51 mg, 100 mol), and 1-ethylimidazole (7.0 L, 75 mol) was prepared, the volume was adjusted to 450 L, and the pH was adjusted to a value of 7.5.
Then, EDC hydrochloride (76.7 mg, 400 mol) was added, and the solution was incubated at 0 °C for 2 d. Subsequently, the mixture was transferred to an NMR tube and analyzed by 31 P-NMR. 
Representative 31 P-NMR Spectra from Oligomerization Assays
Confirmation of Peak Assignments via Spiking with Authentic Samples
The proposed assignment of peaks in 31 P-NMR was confirmed by spiking with authentic samples. For this, a reaction mixture (1.5 mL) initially containing AMP (200 mM), EDC hydrochloride (800 mM) and 1-EtIm (150 mM) that had reacted for 24 h at 0 °C was split into three aliquots (500 L each). Then, pAA (1 mol) was added to the first solution as a solid, pA 2ʹ A (1 mol) was added to the second solution, and the third solution was left unchanged.
The 31 P-NMR spectra (162 MHz, 22 °C) of all three samples were recorded immediately afterwards. This protocol is representative. Figure S22 . Confirmation of peak assignment in 31 P-NMR spectra of AMP oligomerization assays by spiking with authentic samples. A) Spiking with pAA or pA 2' A (assay with starting pH 7.5, no MgCl 2 ); B) spiking with AppAA or AppA 2' A (assay with starting pH 7.5, 80 mM MgCl 2 ); C) Spiking with cyc-pAA (assay at initial pH 7.5, no MgCl 2 ). Figure S23 . Confirmation of peak assignment in 31 P-NMR spectra of AMP and glycine oligomerization assay by spiking with authentic samples. A) Spiking with pAA or pA 2' A (assay with starting pH 7.5, no MgCl 2 ); B) spiking with GlyGlyAA or GlyGlyA 2' A (assay with starting pH 7.5, no MgCl 2 ).
Longest Detectable Oligoadenylates
This protocol describes the determination of long oligoadenylates (up to A 11 ) from AMP oligomerisation assay (pH 7.0) and is representative. An aliquot (50 L) from a reaction mixture initially containing AMP (0.2 M), EDC hydrochloride (0.8 M) and 1-EtIm (0.15 M), that was kept for 7 d at 0 °C in an ice box, was diluted with aqueous Tris buffer solution (2 mL, 20 mM Tris hydrochloride, pH 7.5) and loaded onto a QMA-SepPac cartridge (500 mg, prewashed with Tris buffer solution). Oligomerization products were eluted with a gradient of (NH 4 ) 2 CO 3 in Tris buffer solution (3 mL fractions, 50 mM steps 
Kinetics and Systems Chemistry Analysis
The approach used to measure kinetics by NMR and obtaining rate constants for a systems chemistry analysis of the reaction system was performed analogously to that reported recently for more complex reaction mixtures containing ribonucleotides, organocatalysts and an amino acid. [S4] Representative Protocols and Mops (1 M). The ice-cold solution was immediately placed into an NMR tube and subsequently transferred to the NMR spectrometer set to 1 °C. The first spectrum was acquired 30 min after EDC addition. The following spectra were measured hourly, starting 1 h after the start of the reaction. 1 H-NMR spectra were recorded with presaturation during the recycle delay (d1 = 20s), 31 P-NMR spectra with Bruker pulse program zgig30 (recycle delay d1 = 10 s).
To obtain the concentrations of the species of interest from the 31 P-NMR spectra (AppA, AMP, EDC-AMP), the sum of all integrals was set to 200. The value of the integral of symmetrical pyrophosphate AppA was divided by two to compensate for the symmetry of the analyte. To determine EDC consumption, the sum of all methyl-signals of the ethyl moiety of EDC (linear and cyclic) as well as EDU in the 1 H-NMR spectra were integrated.
Representative NMR spectra Figure S29 , below, lists the reactions for which rate constants were determined. The time dependent concentrations X[t] of the species involved were calculated based on a set of rate equations that were combined in a set of coupled differential equations. The differential equations were integrated using the numerical differential equation solver NDSolve of the Mathematica Software package 11.3. Rate constants were set so as to yield 'best fits' of the experimental data in a series of assay systems of increasing complexity, starting with the hydrolysis of EDC in MOPS buffer (the simplest) and ending with the most complex system containing AMP, EDC, and 1-ethylimidazole. The parameter values determined in the simpler assays were left unchanged in the following, more complex assays, and only those rate constants newly appearing in a given assay were adjusted. 
Mathematical Model
Rate Equations
Listed below is the set of rate equations employed. With this set, the time-dependent concentrations X[t] of the species involved were calculated. As mentioned above, this is a set of coupled equations, so that individual fits to just one plot of a concentration change of one molecular species over time does not suffice to obtain satisfactory solutions. Starting from the hydrolysis of EDC, rate constants were determined via a series of assays of increasing complexity. Representative data is shown below, starting with Figure S28 . Assay with EDC and 1-Ethylimidazole (without AMP)
The starting point of the determination of rate constants was the assay with 1-ethylimidazole and EDC in buffer. Based on the earlier finding that EI-EDC only dissociates but does not hydrolyze, S4 the constant k h0 for the hydrolysis of EDC in the buffer system with 1-etylimidazole was found to be identical that that reported previously. S4 Figure S28a and Figure S28b shows the agreement of the experimental data and the theoretical curve, calculated with k h0 . Next, the rate of formation of EI-EDC was set by comparing the experimental data in the current magnesium-free buffer with those obtained earlier, in magnesium-containing medium. Again, the data agreed with the rate constant found earlier S4 (Figure S28 c) , indicating that magnesium ions do not affect the reaction of the two netneutral or cationic organic molecules. 
Assay with EDC, AMP and 1-Ethylimidazole
The starting point for fitting data from the last assay, containing all components for oligomerization, was the set of constants determined from the earlier assays. The first new rate constants to be determined were those for the formation and hydrolysis of EI-AMP, in agreement with the kinetics of EDC and EDU. The formation occurs via EDC-AMP, a species that also feeds the formation of pyrophosphates and phosphodiesters. Accordingly, the rate constants were determined by fitting to the kinetics of all of species involved. This gave the initial values for k AA and k AppA . All rate constants determined in this, the most complex assay, were iteratively optimized until the best fit was obtained, using the mathematical model with its coupled differential equations. (We cannot rigorously rule out low-level hydrolysis of phosphodiesters under our experimental conditions. However, control experiments with short RNA hairpins under our experimental conditions did not show detectable hydrolysis products, even after more than one week.) The agreement between experimental and theoretical values, as calculated with the model, is shown in Figure 30 , below. [b] See Figure S27 for a list of the reactions.
[c] Pseudo-first order reaction (hydrolysis) or second order reaction. Significant digits reflect estimated uncertainty. Figure S31 . Graphical representation of the fluxes through the two steps of activation, as well as the coupling step, of the reaction network underlying the oligomerization of AMP for the first day of the assay, as obtained by integration using the mathematical model. It can be discerned that the flux through the final coupling step is near-identical in the absence and the presence and the absence of magnesium chloride. The more successful activation steps compensate for the lower reactivity in the phosphodiester-forming step in the absence of MgCl 2 . In the activation process, the rates of formation and hydrolysis of the zwitterionic EI-AMP are both unaffected by the presence of magnesium ions. The formation of EDC-AMP from AMP and EDC is 2.6-fold faster in the absence of MgCl 2 , whereas the hydrolysis of EDC-AMP is only 2.2-fold faster in the absence of the divalent cations (compare Table S1 and Table 1 
